Vivos Therapeutics Inc (NAS:VVOS)
$ 2.1 -0.07 (-3.23%) Market Cap: 6.78 Mil Enterprise Value: 6.27 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 59/100

Vivos Therapeutics Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript

Sep 29, 2021 / 06:20PM GMT
Release Date Price: $100.25 (-6.09%)
Brent Slava
Benzinga - Moderator

It is the CEO of Vivos Therapeutics, its ticker VVOS, Kirk Huntsman. Kirk. Kirk, are you out there?

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO & Chairman

I'm here.

Brent Slava
Benzinga - Moderator

There he is. I knew you were out there.

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO & Chairman

Yes.

Brent Slava
Benzinga - Moderator

How you doing?

Kirk Huntsman
Vivos Therapeutics, Inc. - CEO & Chairman

I'm doing great. Good to see you.

Brent Slava
Benzinga - Moderator

Yes, very good to see you. I like the -- where are you right now? I like the background.

Kirk Huntsman;Brent Slava
Vivos Therapeutics, Inc. - CEO & Chairman;

Yes. I'm in -- I'm at our international training institute in Denver, Colorado.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot